Tenet Healthcare (THC) Tops Q4 EPS by 1c; Provides Wide EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Tenet Reports Results for the Fourth Quarter Ended December 31, 2015 and Issues Outlook for 2016
February 22, 2016 4:29 PM ESTGenerated Adjusted EBITDA of $2.276 billion and Adjusted diluted EPS of $2.05 during calendar year 2015. During the fourth quarter, Tenet generated Adjusted EBITDA of $613 million and Adjusted diluted EPS of $0.35. Issued 2016 Outlook, which includes Adjusted EBITDA of $2.4 billion to $2.5 billion. After normalizing for timing differences related to the California Provider Fee, same-hospital patient revenue increased 3.6% in the fourth quarter, with adjusted admissions increasing 0.3% and revenue per adjusted admission increasing 3.2%. Ambulatory segment revenue increased 12.5% on a pro forma same-facility system-wide basis in the fourth quarter, with cases increasing 6.9% and... More
